vitiligo


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to vitiligo: Ceroid

vitiligo,

condition that causes irregular patches of skin to lose pigment and turn white. The exact cause is unknown, but it occurs when the immune system attacks and destroys melanocytes, the cells that make pigment; the skin does not become raised or painful. Commonly affected areas are the face, elbows and knees, hands and feet, and genitals. Vitiligo can appear at any age and may worsen over time; it is more noticeable in individuals with darker skin. Treatments include ultraviolet light therapy, topical corticosteroid or immunosuppressive creams or gels, skin grafts from normally pigmented areas, opaque foundation makeup and skin dyes to camouflage the affected area, and the depigmenting of the remaining normal skin in extensive cases. Although affected areas sunburn easily and may be associated with certain skin cancers, research has found that a common gene mutation may increase both the chance of vitiligo and lower the risk of melanoma, the most serious form of skin cancer.

Vitiligo

 

a pigmentation disorder manifested by the disappearance of normal pigment from patches of skin. The cause is unknown. It usually starts in youth (more often in females) with the appearance of white spots of different sizes and shapes on unchanged skin. The spots gradually enlarge and coalesce, forming extensive milky-white patches. The hairs on the affected areas turn gray. Foci of vitiligo may occur anywhere on the skin. The affected individuals experience no internal sensations. Treatment consists in using drugs that increase the sensitivity of skin to ultraviolet rays and then exposing the skin to these rays.

vitiligo

[‚vid·əl‚ī·gō]
(medicine)
A skin disease characterized by an acquired ochromia in areas of various sizes and shapes.
Mentioned in ?
References in periodicals archive ?
Therefore, increasing worldwide prevalence of vitiligo is expected to aid in growth of the global vitiligo drugs market over the forecast period.
The 24-month randomized, double-blind, vehicle-controlled phase 2 study of ruxolitinib cream for vitiligo compared the vehicle to four different concentrations of ruxolitinib during the first phase of the study.
Social organizations can be funded for researches about the disease because studies show that vitiligo is one of the most under-researched diseases.
A total of 56 patients with segmental vitiligo were enrolled.
This is a case control study including 98 patients with vitiligo and 98 age- and sex-matched healthy subjects randomly recruited from outpatient dermatology clinics, Sina Hospital, Tabriz, Iran, during spring and summer 2017.
People who suffer from segmental vitiligo also experience loss of hair, eyebrows or eyelashes.
Considering the main possible role of humoral and cellular immune dysfunction in the pathogenesis of vitiligo, recently several studies have assessed calcineurin inhibitors (topical tacrolimus and pimecrolimus) as a safe and efficient therapy for vitiligo in children.
Active vitiligo was defined as the appearance of new lesions or the enlargement of existing lesions in 3 months before the study.
A 36-year-old Sudanese woman presented with an enlarged and painful clitoral mass with vitiligo lesions that was causing sexual difficulties and psychological distress.
The diseases which we came across and included in our study are Vitiligo, Pityriasis versicolor, Pityriasis alba, Nevus anemicus, Nevus depigmentosus, Post-inflammatory hyperpigmentation, Atopic dermatitis, Tinea incognito and Seborrhoeic dermatitis.
New Delhi [India], June 25 ( ANI ): There is considerable stigma attached to vitiligo, which affects about one to two percent of the population worldwide.